PTC Therapeutics, Inc.

PTCT · Healthcare

$70.56

Capitalizzazione: 5.89B USDRendimento da dividendo: —
AdvanceÈ un buon momento per comprare PTC Therapeutics, Inc.? Chiedi a Copenvest AIOttieni un'analisi Advance con AI su timing, rischio e cosa fanno gli investitori tracciati.Chiedi a Copenvest AI

Caricamento grafico…

Notizie

Ultime notizie su questo titolo

Trefis4 set 2026, 21:23

Own Oracle For The AI Boom? PTC's Story Looks Cleaner

ACCESS Newswire2 set 2026, 12:30

Mary Kay Launches Global Brand Platform - Beauty Is More Beautiful Shared(TM) - Celebrating Connection, Community and a New Era of Beauty

PR Newswire27 ago 2026, 12:00

PTC Therapeutics to Participate in Upcoming Investor Conferences

Zacks24 ago 2026, 16:53

KROS $20M Takeda Milestone Adds Cash but Revenue Visibility Stays Weak

PR Newswire24 ago 2026, 12:00

PTC Therapeutics Announces New Sephience™ (sepiapterin) Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and Diet Liberalization as well as Consistent Favorable Safety Profile